Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally Invasive
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Endometrial Cancer
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Enrollment
- 154
- Locations
- 1
- Primary Endpoint
- Determine the feasibility of Narrow Band Imaging (NBI) at the time of thorascopic, laparoscopic or robotic surgery.
- Status
- Completed
- Last Updated
- 7 years ago
Overview
Brief Summary
The purpose of this study is to determine whether narrowband imaging (NBI) makes it easier for a surgeon to see cancer.
NBI is a kind of light. Normally, white light is used during surgery. White light uses many wavelengths of light. NBI only uses two wavelengths which highlight the blood vessels. This makes it easier for the surgeon to see blood vessels. Tumors often have more blood vessels than normal tissue. As a result, NBI may make it easier for the surgeon to see small tumors.
In this study the surgeon will look with both normal white light and NBI. This way a comparison can be made to determine which is superior.
Improved identification of tumors allows doctors and patients to make informed decisions about whether treatment is needed after surgery. It also provides additional information to determine which treatments may be best.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients must meet one (or more) of the following criteria:
- •Preoperative diagnosis of ovarian, fallopian tube, or primary peritoneal carcinoma (all stage, grade and histology)
- •Preoperative diagnosis of grade III endometrial carcinoma (all stage, all histology)
- •Preoperative diagnosis of uterine serous carcinoma (all stage, all grade)
- •Preoperative diagnosis of clear cell endometrial carcinoma (all stage, all grade)
- •Preoperative diagnosis of endometrial carcinosarcoma (all stage, all grade)
- •Gastrointestinal carcinoma (all histology, stage and grade)
- •Pancreatic carcinoma (all histology, stage and grade)
- •Lung cancer (all histology, stage and grade)
- •Esophageal carcinoma (all histology, stage and grade)
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Determine the feasibility of Narrow Band Imaging (NBI) at the time of thorascopic, laparoscopic or robotic surgery.
Time Frame: 1 year
Secondary Outcomes
- Determine what percentage of patients have surface metastasis identified with NBI that were not seen on white light imaging.(1 year)